Mesothelioma UK and Erase Meso award grant for new research into novel drug target for mesothelioma patients

Mesothelioma UK and Erase Meso, two national asbestos-related cancer charities, have agreed to support a six-month research project to the University of Birmingham’s Institute of Cancer and Genomic Sciences. The project is a collaboration between Professor Mathew Coleman at the University of Birmingham and Mathew ColemanProfessors Marion MacFarlane and Anne Willis OBE at the MRC (Medical Research Council) Toxicology Unit at the University of Cambridge, Professor John Le Quesne (CRUK Beatson Institute, Glasgow) and Professor Christopher Schofield (University of Oxford). The project is funded by Erase Meso with a financial…

Read More